| Aptus Pharma Ltd |
|
|
| Initial public issue of upto 18,60,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of Aptus Pharma Limited (the "Company" or "Aptus" or "Issuer") at an issue price of Rs. [*] per equity share (Including a share premium of Rs.[*] per equity share) for cash, aggregating up to Rs. [*] crores ("Public Issue") out of which 94,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 17,66,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs.[*] crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 27.11 % and 25.74 % respectively of the post-issue paid-up equity share capital of the company.
Price Band: Rs. 65/- to Rs. 70/- for equity share of face value of Rs. 10 each.
The floor price is 6.5 times times the face value and cap price is 7.0 times of the face value of the equity shares.
Bids can made for a minimum of 4,000 equity shares and in multiples of 2,000 equity shares thereafter. |
| Issue |
Money Payable On |
| Opens On |
Closes On |
Offer Price |
Application |
| 23-Sep-25 |
25-Sep-25 |
₹ 65.00-70.00 |
₹ 65.00-70.00 |
| Minimum Application for shares in Nos :4000 Further Multiples of :2000 |
| |
|
Lead Managers to the Issue |
| Project Cost |
₹ 0.00 Cr |
| Interactive Financial Services Limited |
|
| Project Financed through Current Offer |
₹ 12.09 Cr |
|
| Post Issue Equity Share Capital |
₹ 6.86 Cr |
|
| Face Value |
₹ 10 |
|
|